Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Exercise or conversion Director acquired 12,666 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Gift Chief Financial Officer gave 5,000 shares (gift)
  8. 4 Open-market sale Former 10% Owner sold 60,000 shares at $15.70 ($942,240)
  9. 4 Planned sale Director sold 9,300 shares at $15.11 ($140,477)
  10. 4 Planned sale Director sold 700 shares at $14.95 ($10,465)
  11. 4 Planned sale Chief Medical Officer sold 2,722 shares at $11.61 ($31,602)
  12. 4 Gift Chief Financial Officer gave 20,000 shares (gift)
  13. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 11,111 shares (option exercise)
  15. 4 Shares withheld for taxes President and CEO gave up 7,688 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 4 Other disposition President and CEO disposed of 56,665 shares (other)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 2,202 shares (to pay taxes)
  19. 4 Open-market buy Director bought 10,000 shares at an average $5.90 ($59,000)
  20. 4 Open-market buy Director bought 10,000 shares at an average $5.45 ($54,450)

Page 2 of 23 · 459 filings